About the “Action Plan to promote the use of market regulatory medicines in the NHS: biosimilar and generic products”

The Spanish Ministry of Health has published its proposal of an Action Plan to foster the use of biosimilar and generic products,
referring to them as medicinal products that regulate the market within the Spanish National Health System. This article comprises some
of the ideas that Faus & Moliner put forward in a personal and independent contribution iled during the period of public consultation of
this document..